SAXUFAR Trademark

Trademark Overview

On Monday, July 28, 2014, a trademark application was filed for SAXUFAR with the United States Patent and Trademark Office. The USPTO has given the SAXUFAR trademark a serial number of 86349555. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 29, 2023. This trademark is owned by Glaxo Group Limited. The SAXUFAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
saxufar

General Information

Serial Number86349555
Word MarkSAXUFAR
Filing DateMonday, July 28, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 29, 2023
Registration Number5220637
Registration DateTuesday, June 13, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 17, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 29, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Friday, December 29, 2023CANCELLED SEC. 8 (6-YR)
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 13, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 13, 2017REGISTERED-PRINCIPAL REGISTER
Monday, May 8, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, April 12, 2017NOTICE OF ALLOWANCE CANCELLED
Monday, May 1, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 12, 2017TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 30, 2017ASSIGNED TO EXAMINER
Wednesday, October 12, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 11, 2016SOU EXTENSION 3 GRANTED
Monday, September 12, 2016SOU EXTENSION 3 FILED
Monday, September 12, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, April 13, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 12, 2016SOU EXTENSION 2 GRANTED
Thursday, March 3, 2016SOU EXTENSION 2 FILED
Tuesday, April 5, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 3, 2016SOU TEAS EXTENSION RECEIVED
Thursday, September 10, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 8, 2015SOU EXTENSION 1 GRANTED
Tuesday, September 8, 2015SOU EXTENSION 1 FILED
Tuesday, September 8, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 14, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 17, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 17, 2015PUBLISHED FOR OPPOSITION
Wednesday, January 28, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 13, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, January 8, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 11, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 11, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 11, 2014ASSIGNED TO LIE
Thursday, December 11, 2014TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, November 17, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, November 17, 2014LETTER OF SUSPENSION E-MAILED
Monday, November 17, 2014SUSPENSION LETTER WRITTEN
Monday, November 10, 2014ASSIGNED TO EXAMINER
Tuesday, August 5, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 31, 2014NEW APPLICATION ENTERED

Related Keywords

saxufar pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological